Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis.
Diabetes Res Clin Pract
; 166: 108346, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: covidwho-912147
ABSTRACT
AIMS:
Diabetes mellitus has been reported to be one of the most prevalent comorbidity in patients with Coronavirus Disease 2019 (COVID-19). We aimed to assess the association of comorbid diabetes with COVID-19 severity or mortality in China.METHODS:
We performed a systematic literature search from six electronic databases on diabetes and COVID-19. The outcome of interest was disease severity or mortality. Heterogeneity among the studies was assessed by the Cochran Q test and the I2 statistic. A random effects model was applied to calculate the pooled risk ratio (RR) with 95% confidence interval (CI).RESULTS:
Nine studies from different provinces/cities were identified according to the predefined inclusion and exclusion criteria. There were a total of 1070 patients with diabetes, out of the 8807 COVID-19 cases. The majority of the cases were derived from Hubei Province. A low degree of heterogeneity in the risk estimates was observed in the included studies. Meta-analysis showed that there was a significant association of preexisting diabetes with disease severity or death. The pooled RR was 2.96 (95% CI 2.31-3.79; p < 0.001). Sensitivity analysis demonstrated no significant changes in the pooled estimates.CONCLUSIONS:
Comorbid diabetes was associated with an increased risk of disease severity or death in Chinese COVID-19 patients.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Infecciones por Coronavirus
/
Complicaciones de la Diabetes
/
Diabetes Mellitus
/
Betacoronavirus
Tipo de estudio:
Estudio observacional
/
Estudio pronóstico
/
Ensayo controlado aleatorizado
/
Revisiones
/
Revisión sistemática/Meta análisis
Tópicos:
Covid persistente
Límite:
Humanos
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Diabetes Res Clin Pract
Asunto de la revista:
Endocrinologia
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
J.diabres.2020.108346
Similares
MEDLINE
...
LILACS
LIS